At week 24 of the year-long study, 14% of patients with early-stage Alzheimer's who received a lower starting dose of the monthly infusion had the brain swelling side effect known as ARIA-E.
Approved by the FDA in July to treat adults with early symptomatic Alzheimer’s disease, Eli Lilly’s Kisunla reduced the brain swelling of patients in a late-stage trial following an adjusted dosing ...
BRAIN-swelling 'sloth fever' could be passed on in the womb, experts fear. Their warning comes after a mum tragically lost her baby before it was born, following infection with the virus.